Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Stimplate (romiplostim biosimilar) / Generium
NCT05220878: Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP	Completed	3	160	RoW	GNR-069, romiplostim, Nplate	AO GENERIUM	Idiopathic Thrombocytopenic Purpura	08/23	10/23
NCT05492409: Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients	Completed	3	160	RoW	GNR-069, romiplostim	AO GENERIUM	Idiopathic Thrombocytopenic Purpura	04/24	04/24